Mark Seierstad

1.2k citations

30 papers · 914 indexed · h-index 17

Impact in

Pharmacology top 5%
- Cannabis and Cannabinoid Research
Toxicology top 5%

Papers in ⓘ

Pharmacology 11
- Cannabis and Cannabinoid Research 11
Toxicology 2

Co-authors: J. Guy Breitenbucher (10 shared papers)Dimitris K. Agrafiotis (2 shared papers)Christopher J. Cramer (4 shared papers)Christopher R. Kinsinger (2 shared papers)Scott E. Denmark (2 shared papers)Michael Webb (9 shared papers)Sandra R. Chaplan (9 shared papers)Brian Scott (8 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)ACS Medicinal Chemistry Letters (6 papers)The Journal of Organic Chemistry (2 papers)Journal of Chemical Information and Modeling (2 papers)Journal of the American Chemical Society (1 paper)
Partner nations: United States Belgium Australia

In The Last Decade

Mark Seierstad

29 papers receiving 900 citations

Peers

Countries citing papers authored by Mark Seierstad

Since Specialization

Citations

This map shows the geographic impact of Mark Seierstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Seierstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Seierstad more than expected).

Fields of papers citing papers by Mark Seierstad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Seierstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Seierstad. The network helps show where Mark Seierstad may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Seierstad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Seierstad Line = papers co-authored together Mark Seierstad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors Journal of Medicinal Chemistry ·Mark Seierstad, J. Guy Breitenbucher	2008	156
2	R3(BΔ23–27)R/I5 Chimeric Peptide, a Selective Antagonist for GPCR135 and GPCR142 over Relaxin Receptor LGR7 Journal of Biological Chemistry ·Chester Kuei, Steven W. Sutton, Pascal Bonaventure, Cindy M. Pudiak, Jonathan Shelton, Jessica Zhu, Diane Nepomuceno, Jiejun Wu, Jing‐Cai Chen, Fredrik Kamme, Mark Seierstad, Michael D. Hack, Ross A. D. Bathgate, Mohammed Akhter Hossain, John D. Wade, John Atack, Timothy W. Lovenberg, Changlu Liu	2007	116
3	Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase Bioorganic & Medicinal Chemistry Letters ·John M. Keith, Richard L. Apodaca, Wei Xiao, Mark Seierstad, Kanaka Pattabiraman, Jiejun Wu, Michael Webb, Mark J. Karbarz, Sean M. Brown, Sandy Wilson, Brian Scott, Chui‐Se Tham, Lin Luo, James A. Palmer, Michelle Wennerholm, Sandra R. Chaplan, J. Guy Breitenbucher	2008	76
4	A QSAR Model of hERG Binding Using a Large, Diverse, and Internally Consistent Training Set Chemical Biology & Drug Design ·Mark Seierstad, Dimitris K. Agrafiotis	2006	65
5	Design Optimization of 1,3-Diphospha-2,4-diboretane Diradicals Angewandte Chemie International Edition ·Mark Seierstad, Christopher R. Kinsinger, Christopher J. Cramer	2002	56
6	Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins Neuron ·Michael P. Maher, José A. Matta, Shenyan Gu, Mark Seierstad, David S. Bredt	2017	51
7	Preclinical Characterization of the FAAH Inhibitor JNJ-42165279 ACS Medicinal Chemistry Letters ·John M. Keith, W. M. Jones, Mark S. Tichenor, Jing Liu, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy J. Wilson, Lin Luo, Michelle Wennerholm, Leon Chang, Michèle Rizzolio, Raymond Rynberg, Sandra R. Chaplan, J. Guy Breitenbucher	2015	47
8	Tandem Cycloaddition Chemistry of Nitroalkenes: Preparative and Theoretical Studies on the Stereochemical Course of [3 + 2] Cycloaddition of Cyclic Nitronates The Journal of Organic Chemistry ·Scott E. Denmark, Mark Seierstad, B. Herbert	1999	33
9	Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate ACS Medicinal Chemistry Letters ·John M. Keith, Richard L. Apodaca, Mark S. Tichenor, Wei Xiao, W. M. Jones, Joan M. Pierce, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy Wilson, Lin Luo, Michelle Wennerholm, Leon Chang, Sean M. Brown, Michèle Rizzolio, Raymond Rynberg, Sandra R. Chaplan, J. Guy Breitenbucher	2012	31
10	Design Optimization of 1,3-Diphospha-2,4-diboretane Diradicals Angewandte Chemie ·Mark Seierstad, Christopher R. Kinsinger, Christopher J. Cramer	2002	28
11	Library Enhancement through the Wisdom of Crowds Journal of Chemical Information and Modeling ·Michael D. Hack, Dmitrii N. Rassokhin, Christophe Buyck, Mark Seierstad, Andrew Skalkin, Peter ten Holte, Todd K. Jones, Taraneh Mirzadegan, Dimitris K. Agrafiotis	2011	28
12	Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH) Bioorganic & Medicinal Chemistry Letters ·Amy Timmons, Mark Seierstad, Richard L. Apodaca, Matt Epperson, Dan Pippel, Sean M. Brown, Leon Chang, Brian Scott, Michael Webb, Sandra R. Chaplan, J. Guy Breitenbucher	2008	25
13	Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase Bioorganic & Medicinal Chemistry Letters ·John M. Keith, W. M. Jones, Joan M. Pierce, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Brian Scott, Sandy J. Wilson, Lin Luo, Michelle Wennerholm, Leon Chang, Sean M. Brown, Michèle Rizzolio, Raymond Rynberg, Sandra R. Chaplan, J. Guy Breitenbucher	2014	24
14	Tandem Cycloaddition Chemistry of Nitroalkenes: Probing the Remarkable Stereochemical Influence of the Lewis Acid The Journal of Organic Chemistry ·Scott E. Denmark, Mark Seierstad	1999	22
15	Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites Bioorganic & Medicinal Chemistry Letters ·Mark S. Tichenor, John M. Keith, W. M. Jones, Joan M. Pierce, Jeffrey E. Merit, Natalie A. Hawryluk, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Sandy J. Wilson, Michelle Wennerholm, Filip Woestenborghs, D. Beerens, Lin Luo, Sean M. Brown, Marlies De Boeck, Sandra R. Chaplan, J. Guy Breitenbucher	2012	20
16	Biradical and Zwitterionic Cyclizations of Oxy-Substituted Enyne-Allenes Organic Letters ·Christopher J. Cramer, Bethany L. Kormos, Mark Seierstad, Edward C. Sherer, Paul Winget	2001	20
17	Predicting the Binding of Fatty Acid Amide Hydrolase Inhibitors by Free Energy Perturbation Journal of Chemical Theory and Computation ·Arjun Saha, Amy Y. Shih, Taraneh Mirzadegan, Mark Seierstad	2018	18
18	Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators ACS Medicinal Chemistry Letters ·Brad M. Savall, Dongpei Wu, Devin M. Swanson, Mark Seierstad, Nyantsz Wu, Jorge Vives Martinez, Beatriz García Olmos, Brian Lord, Kevin J. Coe, Tatiana Koudriakova, Timothy W. Lovenberg, Nicholas I. Carruthers, Michael P. Maher, Michael K. Ameriks	2018	16
19	The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor Bioorganic & Medicinal Chemistry Letters ·Devin M. Swanson, Victoria Wong, Jill A. Jablonowski, Chandra Shah, Dale A. Rudolph, Curt A. Dvorak, Mark Seierstad, Lisa Dvorak, Kirsten L. Morton, Diane Nepomuceno, John Atack, Pascal Bonaventure, Timothy W. Lovenberg, Nicholas I. Carruthers	2011	13
20	Experimental and Theoretical Characterization of the 3,5-Didehydrobenzoate Anion: A Negatively Charged meta-Benzyne Journal of the American Chemical Society ·Jason M. Price, Katrina Emilia Nizzi, J. Larry Campbell, Hilkka I. Kenttämaa, Mark Seierstad, Christopher J. Cramer	2002	13

About Mark Seierstad

Mark Seierstad is a scholar working on Pharmacology, Toxicology, Cellular and Molecular Neuroscience, Pathology and Forensic Medicine and Organic Chemistry, having authored 30 papers that have together received 914 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (11 papers), Alcohol Consumption and Health Effects (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Computational Drug Discovery Methods (3 papers), Receptor Mechanisms and Signaling (3 papers), Chemical Synthesis and Analysis (3 papers) and Polyamine Metabolism and Applications (3 papers). The work is most often cited by research in Pharmacology (317 citations), Toxicology (64 citations), Cellular and Molecular Neuroscience (172 citations), Organic Chemistry (252 citations) and Computational Theory and Mathematics (103 citations). Mark Seierstad has collaborated with scholars based in United States, Belgium and Australia. Frequent co-authors include J. Guy Breitenbucher, Dimitris K. Agrafiotis, Christopher J. Cramer, Christopher R. Kinsinger, Scott E. Denmark, Michael Webb, Sandra R. Chaplan, Brian Scott, Michelle Wennerholm and Mark J. Karbarz. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, The Journal of Organic Chemistry, Journal of Chemical Information and Modeling and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact